{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:18:00Z","timestamp":1790050680044,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":2984,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1097\/jto.0b013e3181560dcc","type":"journal-article","created":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T10:41:25Z","timestamp":1209897685000},"page":"947-952","source":"Crossref","is-referenced-by-count":35,"title":["Targeting Lewis Y (Ley) in Small Cell Lung Cancer with a Humanized Monoclonal Antibody, hu3S193: A Pilot Trial Testing Two Dose Levels"],"prefix":"10.1016","volume":"2","author":[{"given":"Lee M.","family":"Krug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Milton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim A.","family":"Jungbluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Chi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Quaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeta","family":"Pandit-Taskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Kris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Smith-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Old","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaitanya","family":"Divgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e3181560dcc_bib1","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/jnci\/83.9.609","article-title":"Antigens of lung cancer: results of the Second International Workshop on Lung Cancer Antigens","volume":"83","author":"Souhami","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/oxfordjournals.annonc.a058193","article-title":"Phase I\/II study of monoclonal antibody against Lewis Y hapten in relapsed small-cell lung cancer","volume":"3","author":"Stahel","year":"1992","journal-title":"Ann Oncol"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199207023270103","article-title":"Correlation of expression of H\/Le(y)\/Le(b) antigens with survival in patients with carcinoma of the lung","volume":"327","author":"Miyake","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/(SICI)1097-0215(19970926)73:1<50::AID-IJC9>3.0.CO;2-0","article-title":"Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens","volume":"73","author":"Zhang","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib5","doi-asserted-by":"crossref","first-page":"12957","DOI":"10.1073\/pnas.91.26.12957","article-title":"Specificity analysis of blood group Lewis-y (Le(y)) antibodies generated against synthetic and natural Le(y) determinants","volume":"91","author":"Kitamura","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib6","first-page":"3254","article-title":"Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors","volume":"60","author":"Scott","year":"2000","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib7","first-page":"3621","article-title":"Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy","volume":"6","author":"Clarke","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib8","first-page":"716","article-title":"Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model","volume":"47","author":"Kelly","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib9","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1158\/1078-0432.CCR-04-0037","article-title":"Antibody-targeted chemotherapy with the calicheamicin conjugate hu3S193-N-acetyl gamma calicheamicin dimethyl hydrazide targets Lewisy and eliminates Lewis y-positive human carcinoma cells and xenografts","volume":"10","author":"Boghaert","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib10","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1158\/1078-0432.CCR-07-0284","article-title":"A phase 1 biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3S193 in patients with advanced epithelial cancers that express the Lewis-Y antigen","volume":"13","author":"Scott","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib11","first-page":"829","article-title":"Evaluation of the in vivo biodistribution of yttrium-labeled isomers of CHX-DTPA-conjugated monoclonal antibodies","volume":"39","author":"Kobayashi","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib12","first-page":"5237","article-title":"In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen","volume":"60","author":"Smith-Jones","year":"2000","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib13","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/0076-6879(86)21067-8","article-title":"Determination of the true immunoreactive fraction of monoclonal antibodies after radiolabeling","volume":"121","author":"Lindmo","year":"1986","journal-title":"Methods Enzymol"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib14","first-page":"6851","article-title":"Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33","volume":"61","author":"Ritter","year":"2001","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib15","first-page":"79","article-title":"Tumor cell lysis and tumor growth inhibition by the isotype variants of MAb BR55-2 directed against Y oligosaccharide","volume":"5","author":"Steplewski","year":"1991","journal-title":"In Vivo"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib16","first-page":"A974","article-title":"Anti-Lewis Y (LeY) monoclonal antibody (mAb) BR55-2 (IgG2a) in patients with advanced breast cancer","volume":"13","author":"Theodoulou","year":"1994","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nm0396-350","article-title":"Treatment of advanced solid tumors with immunotoxin LMB-1: an antibody linked to Pseudomonas exotoxin","volume":"2","author":"Pai","year":"1996","journal-title":"Nat Med"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib18","first-page":"1720","article-title":"Imaging and phase I study of 111In- and 90Y-labeled anti-LewisY monoclonal antibody B3","volume":"6","author":"Pai-Scherf","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib19","doi-asserted-by":"crossref","first-page":"A2624","DOI":"10.1200\/jco.2004.22.14_suppl.2624","article-title":"Results from a phase I clinical trial with IGN311, a fully humanized IgG1 antibody against Lewis Y in patients with solid tumors expressing Lewis Y antigen","author":"Oruzio","year":"2004","journal-title":"Proc Am Sci Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib20","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1126\/science.8327892","article-title":"Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates","volume":"261","author":"Trail","year":"1993","journal-title":"Science"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib21","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1200\/JCO.2000.18.11.2282","article-title":"Phase I trial of the anti-Lewis Y drug immunoconjugate BR96-doxorubicin in patients with Lewis Y-expressing epithelial tumors","volume":"18","author":"Saleh","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib22","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1200\/JCO.1999.17.2.478","article-title":"Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancer","volume":"17","author":"Tolcher","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181560dcc_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lungcan.2006.05.020","article-title":"A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma","volume":"54","author":"Ross","year":"2006","journal-title":"Lung Cancer"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415308959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415308959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T02:18:51Z","timestamp":1557541131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415308959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S1556086415308959"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e3181560dcc","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}